Zenith Drugs Limited, a active public limited company, was established on 15 November 2000 in Depalpur, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231MP2000PLC014465. Registered under ROC Roc Gwalior. it is listed. It has an authorized capital of ₹22.40 Cr and a paid-up capital of ₹17.15 Cr.
It upholds a compliant status. In 2024, it reported revenue of ₹133.74 Cr and a net worth of ₹62.22 Cr. Employing 99 professional, Its leadership includes Deendayal Kumawat (Director), Ajay Singh Dassundi (Director), Bhupesh Soni (Director). Past directors included Ajay Singh Dassundi, Sandeep Bhardwaj. It holds ₹110.89 Cr open charges and ₹109.84 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at K. No. 72/5, Village Muradpura, Depalpur, Madhya Pradesh, 453001.
L24231MP2000PLC014465
014465
15 November 2000
₹22.40 Cr
₹17.15 Cr
Roc Gwalior
Listed
Active
Explore comprehensive insights into Zenith Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deendayal Kumawat | Director | 25 Sep 2023 | Current |
| Ajay Singh Dassundi | Director | 25 Jun 2015 | Current |
| Bhupesh Soni | Director | 15 Mar 2001 | Current |
| Sandeep Bhardwaj | Managing Director | 31 Oct 2003 | Current |
| Ranjana Sehgal | Director | 16 Sep 2023 | Current |
| Anil Malik | Director | 25 Sep 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2012 | Past |
| Pramod Abcsdd | Director | 15 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zenith Drugs Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 15.54% increase. The company also saw a substantial improvement in profitability, with a 95.38% increase in profit. The company's net worth Soared by an impressive increase of 250.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Zenith Drugs had a promoter holding of 69.98% and a public holding of 30.02%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,108,859,653.00
₹1,098,385,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2025 | Sidbi | ₹9.20 M | Open |
| 26 Mar 2025 | Sidbi | ₹2.03 Cr | Open |
| 10 Mar 2025 | Sbicap Trustee Company Limited | ₹76.98 Cr | Open |
| 17 Oct 2024 | Others | ₹5.19 M | Open |
| 26 Jun 2024 | Sidbi | ₹7.50 M | Open |
Explore comprehensive loan charge details -
Zenith Drugs has a workforce of 99 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zenith Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenith Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Zenith Drugs Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.
A charge with Sidbi amounted to Rs. 0.92 Cr with Charge ID 101184755 was registered on 22 Sep 2025. was recorded as a recent event.
The activity Zenith Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.
The activity A charge with Sidbi amounted to Rs. 2.03 Cr with Charge ID 101074698 was registered on 26 Mar 2025. was completed.
Progress on A charge registered on 19 Oct 2024 via Charge ID 101000220 with State Bank Of India was fully satisfied on 20 Mar 2025. was documented.
The activity A charge with Sbicap Trustee Company Limited of Rs. 76.98 Cr registered on 10 Mar 2025 with Charge ID 101071178 was modified on 12 Mar 2025. was completed.
The CIN of Zenith Drugs Limited is L24231MP2000PLC014465.
Zenith Drugs Limited is headquartered at K. No. 72/5, Village Muradpura, Depalpur, Madhya Pradesh, 453001.
Zenith Drugs Limited was incorporated on 15 November 2000.
The current directors of Zenith Drugs Limited are
The primary industry of Zenith Drugs Limited is Manufacturing.
Zenith Drugs Limited is listed.
The authorized capital of Zenith Drugs Limited is ₹22.40 Cr, and the paid-up capital is ₹17.15 Cr.
The compliance status of Zenith Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX